ArticleWorld journal of surgical oncology2025
Indocyanine green-assisted liver resection for colorectal liver metastases and factors associated with resection margin: a single-center retrospective study.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical practice of indocyanine green fluorescence imaging in robotic liver surgery - a global expert survey.Surgical endoscopy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to compare the short-term outcomes of Indocyanine Green (ICG) assisted minimally invasive surgery (MIS) with Intraoperative Ultrasound (IOUS) against conventional MIS with IOUS alone and open surgery with tactility and IOUS for colorectal liver metastases (CRLM). And identify risk factor of R1 resection (tumor-negative margin < 1 mm) by statistical analysis. MATERIALS AND
methodsA retrospective cohort analysis was conducted on 86 patients with 158 CRLM tumors undergoing hepatectomy. Patients were categorized into three groups: Group A (ICG + IOUS MIS, n = 14, tumor = 23), Group B (IOUS only MIS, n = 16, tumor = 20), and Group C (tactile + IOUS Open surgery, n = 56, tumor = 115). Statistical analysis involved univariate analysis and multivariable logistic regression were performed.
resultsGroup A demonstrated superior R0 resection (tumor-negative margin ≥ 1 mm) rates, shorter median hospital stays compared to Groups C. Intraoperatively, Group A exhibited reduced blood loss and shorter operative times (213.5 vs. 351.5 min, p = 0.02) compared to Group C. Multivariable analysis identified surgical approach, lower Ki-67 expression, higher body weight and more metastatic lesions as independent predictors of R1 resection.
conclusionICG assisted MIS significantly reduces R1 resection rates, postoperative hospitalization time and costs compared to conventional MIS or open surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.